Updated immunisation reference page: Tetanus
We have recently updated our tetanus reference page.
Tetanus is caused when exotoxins from the bacteria Clostridium Tetani enter the bloodstream and act on the central nervous system. Symptoms include muscle rigidity and painful spasms.
The new reference page includes new details on tetanus epidemiology, and detailed guidance on tetanus vaccination and the appropriate tetanus-prevention management of tetanus-prone wounds.
Updated immunisation reference page: Pertussis
We have recently updated our pertussis reference page.
Pertussis (commonly known as whooping cough) is a highly contagious respiratory disease. Pertussis is usually more serious in infants under 6 months, but it can affect people of any age.
The updated page includes new details on pertussis epidemiology and more information about transmission. We have also published detailed guidance and recommendations for primary course and booster vaccinations across age groups.
Updated immunisation reference page: Zoster (herpes zoster)
We have recently updated our zoster (also known as shingles) reference page.
Zoster is the reactivation of the varicella zoster virus (VZV) in people who have previously had varicella (chickenpox) infection. Zoster presents with a painful blistering rash. The most common side effect is post-herpetic neuralgia.
The updated page includes new details on eligibility for the upcoming National Immunisation Program (NIP) funding for Shingrix, commencing on 1 November 2023. The page also features commonly asked questions on zoster and Shingrix.
Updated immunisation reference page: Varicella
We have recently updated our varicella reference page.
Varicella (chickenpox) is a highly contagious disease caused by infection with the varicella–zoster virus (VZV).
The updated reference page includes more details on varicella symptoms and transmission, a new section on epidemiology and more comprehensive advice on vaccination (including information on side effects, precautions and contraindications).
Updated immunisation reference page: MTHFR gene
We have recently updated our reference page on MTHFR gene polymorphisms.
The MTHFR gene is involved in the production of the methylenetetrahydrofolate reductase (MTHFR) enzyme, which helps the body to break down folate.
People who have MTHFR gene polymorphisms (harmless changes to the gene which are very common) can safely receive vaccines.
The updated reference page reflects up-to-date research showing MTHFR gene polymorphisms do not cause any significant health problems.
Updated immunisation reference page: Yellow fever
We have recently updated our Yellow fever reference page.
Yellow fever is an acute viral haemorrhagic disease which can be transmitted to humans via the bites of mosquitos infected with yellow fever virus (YFV). Vaccination against yellow fever is a requirement to travel to and from certain countries.
The updated reference page includes information on yellow fever epidemiology, transmission and prevention.
New immunisation reference page: RSV
Respiratory syncytial virus (RSV) is one of the leading causes of respiratory tract infections in young children. There are currently no RSV vaccines registered for use in Australia. However, there are many vaccines under development in clinical trials.
MVEC has recently published an RSV reference page which includes information on symptoms, transmission and prevention.
MVEC: Respiratory syncytial virus (RSV)
Updated immunisation reference page: Epilepsy and immunisation
We have recently updated our Epilepsy and immunisation reference page.
The updated page includes the most recent recommendations for immunisation of children with Dravet syndrome and other children with vaccine-proximate seizures.
Updated – MVEC: Epilepsy and immunisation
Updated immunisation reference page: COVID-19
We have recently updated our COVID-19 immunisation reference page to streamline information. You can now find COVID-19 information and recommendations for adults and children on one page.
The updated page outlines the vaccines currently available, primary schedules and booster dose recommendations across age groups and for special risk groups. The page also includes answers to commonly asked questions.
For other COVID-19-related information, see:
MVEC: COVID-19 vaccines and allergy
New immunisation reference page: Haemophilus influenzae type B (Hib)
Haemophilus influenzae type B (Hib) is a vaccine-preventable strain of haemophilus influenzae bacteria. Even with treatment, 3% of Hib meningitis cases occurring in developed countries will be fatal and 10-30% of cases will have permanent neurological complications.
Before vaccination was included on the National Immunisation Program (NIP) in 1992, Hib was the biggest cause of invasive bacterial infection in children in Australia. Since then, the number of Hib infections notified has reduced by 95%.
Our new immunisation reference page includes information on Hib transmission, epidemiology and prevention.
MVEC: Haemophilus influenzae type B (Hib)